rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
AstraZeneca Pharma India Ltd. - Research Center
506820 ASTRAZEN Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Sources of funds
Owner's fund
Equity share capital 5.00 5.00 5.00 5.00 5.00
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 583.69 506.39 451.17 359.44 295.80
Loan funds
Secured loans - - - - -
Unsecured loans - - - - -
Total 588.69 511.39 456.17 364.44 300.80
Uses of funds
Fixed assets
Gross block 165.14 158.64 159.78 132.84 119.83
Less : revaluation reserve - - - - -
Less : accumulated depreciation 96.28 84.15 78.82 61.31 45.00
Net block 68.86 74.49 80.96 71.53 74.83
Capital work-in-progress 1.33 2.20 4.02 24.24 6.90
Investments - - - - -
Net current assets
Current assets, loans & advances 914.68 779.87 689.73 610.59 480.07
Less : current liabilities & provisions 396.18 345.17 318.54 341.92 261.00
Total net current assets 518.50 434.70 371.19 268.67 219.07
Miscellaneous expenses not written - - - - -
Total 588.69 511.39 456.17 364.44 300.80
Notes:
Book value of unquoted investments - - - - -
Market value of quoted investments - - - - -
Contingent liabilities 132.28 124.60 89.17 69.19 32.57
Number of equity sharesoutstanding (Lacs) 250.00 250.00 250.00 250.00 250.00
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close